Gallbladder cancer (GBC) is one of the most common and aggressive diseases among the gastrointestinal tract malignancies, and the molecular mechanism underlying this disease remains largely unknown. CIZ1 (Cip1 interacting zinc finger protein 1), a binding partner of p21Cip1/Waf1, has been found to be involved in the tumorigenesis recently. However, the expression pattern and biological functions of CIZ1 in the progression of GBC are not fully understood. In this study, it was found that the expression of CIZ1 was significantly elevated in GBC samples compared to their adjacent normal tissues. Moreover, overexpression of CIZ1 promoted the growth and migration of GBC cells, while knocking down the expression of CIZ1 inhibited the growth, migration, and tumorigenesis of GBC cells in vitro and in vivo. Mechanistically, CIZ1 was found to interact with TCF4 (T-cell factor) and activate beta-catenin/TCF signaling. Our study demonstrated that CIZ1 played an oncogenic role in the progression of GBC and CIZ1 might be a promising target for the treatment of GBC.
CIZ1 Gallbladder cancer Cell growth and migration Beta-catenin/TCF
This is a preview of subscription content, log in to check access.
This work was supported by the National Natural Science Foundation of China (81272728), the Foundation of Shanghai Science and Technology IIJC1416202, and the Foundation 201440338 from Shanghai.
Saika K, Machii R. Five-year relative survival rate of gallbladder cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2014;44(7):704.CrossRefPubMedGoogle Scholar
Nishibe R, Watanabe W, Ueda T, et al. CIZ1, a p21Cip1/Waf1-interacting protein, functions as a tumor suppressor in vivo. FEBS Lett. 2013;587(10):1529–35.CrossRefPubMedGoogle Scholar
Mitsui K, Matsumoto A, Ohtsuka S, Ohtsubo M, Yoshimura A. Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, CIZ1. Biochem Biophys Res Commun. 1999;264(2):457–64.CrossRefPubMedGoogle Scholar
Copeland NA, Sercombe HE, Ainscough JF, Coverley D. CIZ1 cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro. J Cell Sci. 2010;123(Pt 7):1108–15.CrossRefPubMedPubMedCentralGoogle Scholar
Yin J, Wang C, Tang X, et al. CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells. Mol Med Rep. 2014;8(6):1630–4.Google Scholar
Judex M, Neumann E, Lechner S, et al. Laser-mediated microdissection facilitates analysis of area-specific gene expression in rheumatoid synovium. Arthritis Rheum. 2003;48(1):97–102.CrossRefPubMedGoogle Scholar
Dahmcke CM, Buchmann-Moller S, Jensen NA, Mitchelmore C. Altered splicing in exon 8 of the DNA replication factor CIZ1 affects subnuclear distribution and is associated with Alzheimer’s disease. Mol Cell Neurosci. 2008;38(4):589–94.CrossRefPubMedGoogle Scholar
Ma L, Chen R, Wang L, Yang Y, Wan X. No mutations in CIZ1 in twelve adult-onset primary cervical dystonia families. Mov Disord. 2013;28(13):1899–901.CrossRefPubMedGoogle Scholar
den Hollander P, Rayala SK, Coverley D, Kumar R. CIZ1, a novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action. Cancer Res. 2006;66(22):11021–9.CrossRefGoogle Scholar
Warder DE, Keherly MJ. CIZ1, Cip1 interacting zinc finger protein 1 binds the consensus DNA sequence ARYSR(0–2)YYAC. J Biomed Sci. 2003;10(4):406–17.PubMedGoogle Scholar
Rahman FA, Aziz N, Coverley D. Differential detection of alternatively spliced variants of CIZ1 in normal and cancer cells using a custom exon-junction microarray. BMC Cancer. 2010;10:482.CrossRefPubMedPubMedCentralGoogle Scholar
Ghosh M, Sakhuja P, Singh S, Agarwal AK. p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer. Saudi J Gastroenterol. 2013;19(1):34–9.CrossRefPubMedPubMedCentralGoogle Scholar
Moon WS, Park HS, Lee H, et al. Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer. Cancer Res Treat. 2005;37(3):171–6.CrossRefPubMedPubMedCentralGoogle Scholar
Kimura Y, Furuhata T, Mukaiya M, et al. Frequent beta-catenin alteration in gallbladder carcinomas. J Exp Clin Cancer Res. 2003;22(2):321–8.PubMedGoogle Scholar